Morbidity and mortality risk among patients with screening-detected severe hypertension in the Malmö Preventive

Christina Westerdahl1, Bengt Zöller, Eren Arslan

  • 1aLund University, Department of Clinical Science, University Hospital, Sweden bIstanbul University Cerrahapsa School of Medicine, Kocamustafapasa, Fatih, Istanbul, Turkey.

Journal of Hypertension
|September 10, 2014
PubMed

Insights

Severe hypertension is linked to metabolic syndrome and family history. Individuals with severe hypertension face higher risks of mortality, cardiovascular events, and diabetes, even with treatment, necessitating better risk factor management.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Hypertension screening is crucial for early detection and treatment.
  • Severe hypertension (grade 3) is a significant predictor of cardiovascular disease.
  • Population-based screening and intervention programs are vital for managing hypertension.

Purpose of the Study:

  • To identify risk factors for developing severe hypertension.
  • To evaluate the prospective morbidity and mortality risks associated with severe hypertension.
  • To analyze outcomes in a population-based screening and intervention program.

Main Methods:

  • A population-based cohort of 18,200 individuals in Malmö, Sweden, was examined at baseline (1972-1992) and re-examined (2002-2006).
  • Severe hypertension (300 individuals, 1.6%) was identified at re-examination, with baseline risk factors analyzed.
  • Morbidity and mortality data were tracked in national registers, with Cox analyses used for hazard ratios.

Main Results:

  • Men with severe hypertension showed baseline metabolic syndrome variables and paternal hypertension history.
  • Women with severe hypertension had elevated BMI and maternal hypertension history.
  • Severe hypertension patients had higher risks of mortality, coronary events, stroke, and diabetes, with coronary event risk remaining elevated (HR 2.31).

Conclusions:

  • Family history and metabolic syndrome indicators predict severe hypertension long-term.
  • Severe hypertension increases mortality, cardiovascular morbidity, and diabetes risk despite treatment.
  • Improved risk factor control is essential for managing severe hypertension.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
775
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.6K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
913
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.2K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
1.6K